Scarica l'app Stockscreener
4.45
5.32%
-0.25
Dopo l'orario di chiusura:
4.50
0.05
+1.12%
Precedente Chiudi:
$4.70
Aprire:
$4.75
Volume 24 ore:
51,402
Relative Volume:
0.02
Capitalizzazione di mercato:
$192.57M
Reddito:
-
Utile/perdita netta:
$-33.65M
Rapporto P/E:
-1.00
EPS:
-4.45
Flusso di cassa netto:
$-20.83M
1 W Prestazione:
+13.52%
1M Prestazione:
+14.10%
6M Prestazione:
+159.91%
1 anno Prestazione:
+99.54%
Intervallo 1D:
$4.38
$4.75
Intervallo di 1 settimana:
$3.90
$4.86
Portata 52W:
$1.15
$12.46
Minerva Neurosciences Inc Stock (NERV) Company Profile
Nome
Minerva Neurosciences Inc
Settore
Industria
Telefono
617-600-7373
Indirizzo
1500 DISTRICT AVENUE, BURLINGTON, MA
Confronta NERV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
4.45 | 203.39M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-06-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-14 | Iniziato | BTIG Research | Buy |
| 2019-10-02 | Reiterato | Chardan Capital Markets | Buy |
| 2019-09-25 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-18 | Iniziato | William Blair | Outperform |
| 2019-05-31 | Iniziato | H.C. Wainwright | Buy |
| 2017-09-01 | Iniziato | Citigroup | Buy |
| 2017-03-06 | Ripresa | Jefferies | Buy |
| 2016-05-12 | Ripresa | Jefferies | Buy |
Mostra tutto
Minerva Neurosciences Inc Borsa (NERV) Ultime notizie
Minerva Neurosciences Inc (NERV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Minerva Neurosciences Inc. (4MNA) stock attractive for dividend growth2025 Trading Volume Trends & Long-Term Capital Growth Strategies - ulpravda.ru
Is Minerva Neurosciences Inc. stock attractive for hedge fundsJuly 2025 Technicals & Real-Time Buy Signal Notifications - ulpravda.ru
Why Minerva Neurosciences Inc. stock is in analyst buy zone2025 Analyst Calls & Long-Term Investment Growth Plans - ulpravda.ru
Is Minerva Neurosciences Inc. stock safe for conservative investorsJuly 2025 Retail & Reliable Trade Execution Plans - ulpravda.ru
Why Minerva Neurosciences Inc. stock is rated strong buyJuly 2025 Momentum & Consistent Return Investment Signals - ulpravda.ru
Will Minerva Neurosciences Inc. (4MNA) stock top growth indexes2025 Momentum Check & Reliable Momentum Entry Alerts - ulpravda.ru
Minerva Neurosciences (NASDAQ:NERV) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Minerva Neurosciences (NASDAQ:NERV) & UCB (OTCMKTS:UCBJY) Head to Head Analysis - Defense World
Working capital per share of Minerva Neurosciences Inc – MUN:4MNA - TradingView — Track All Markets
Gains Recap: Why Minerva Neurosciences Inc stock is in analyst buy zoneProduct Launch & Free Expert Verified Stock Movement Alerts - moha.gov.vn
MSN Money - MSN
Published on: 2025-12-26 01:20:46 - moha.gov.vn
Reviewing Xenetic Biosciences (NASDAQ:XBIO) and Minerva Neurosciences (NASDAQ:NERV) - Defense World
Minerva Neurosciences shareholders approve key governance measures - MSN
Minerva Neurosciences Shareholders Approve Key Governance Measures - TipRanks
Risks Report: Why Minerva Neurosciences Inc. (4MNA) stock stays resilientMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Movement Recap: Why analysts upgrade Minerva Neurosciences Inc. stock2025 Growth vs Value & AI Powered Market Entry Ideas - Улправда
How strong is Minerva Neurosciences Inc. stock revenue growthGold Moves & Weekly High Return Forecasts - Улправда
Why analysts upgrade Minerva Neurosciences Inc. stockIndex Update & Risk Controlled Swing Alerts - Улправда
What risks investors should watch in Minerva Neurosciences Inc. stock2025 Earnings Impact & Real-Time Volume Analysis - Улправда
Inderjit Kaul Net Worth (2025) - GuruFocus
Minerva Neurosciences (NERV) Price Target Increased by 12.50% to 4.59 - Nasdaq
Is Minerva Neurosciences Inc. stock a buy for dividend growth2025 EndofYear Setup & Safe Entry Zone Tips - Newser
How risky is Minerva Neurosciences Inc. (4MNA) stock compared to peersPortfolio Performance Report & Long Hold Capital Preservation Plans - Newser
How Minerva Neurosciences Inc. stock reacts to oil prices2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Minerva jumps on phase III funding, leading neuro stocks - BioWorld MedTech
Is Minerva Neurosciences Inc. stock attractive for retirement portfolios2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst - MSN
Will Minerva Neurosciences Inc. (4MNA) stock boost dividends furtherSell Signal & Fast Exit and Entry Strategy Plans - Newser
Is Minerva Neurosciences Inc. (4MNA) stock cheap vs fundamentalsJuly 2025 Action & Verified Swing Trading Watchlist - Newser
Minerva Neurosciences (NERV) Stock Analysis Report | Financials & Insights - Benzinga
How Minerva Neurosciences Inc. (4MNA) stock compares with tech leadersJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Market Fear: Why Minerva Neurosciences Inc 4MNA stock stays resilientJuly 2025 Outlook & Capital Efficiency Focused Ideas - moha.gov.vn
How Minerva Neurosciences Inc. stock trades during market volatilityJuly 2025 Catalysts & Free Low Drawdown Momentum Trade Ideas - moha.gov.vn
Performance Recap: What risks investors should watch in Minerva Neurosciences Inc. stock2025 Market Trends & Consistent Return Strategy Ideas - BỘ NỘI VỤ
Contrasting Minerva Neurosciences (NASDAQ:NERV) and Madrigal Pharmaceuticals (NASDAQ:MDGL) - Defense World
Is Transindia Real Estate Limited Undervalued or Overvalued Fair Value ExplainedTechnical Analysis Insights & Zero-Cost Stock Research by Professionals - earlytimes.in
Why Minerva Neurosciences Inc. stock appeals to analysts2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
Why Minerva Neurosciences Inc. (4MNA) stock attracts wealthy investorsPortfolio Growth Summary & High Conviction Buy Zone Picks - newser.com
Using Ichimoku Cloud for Minerva Neurosciences Inc. technicalsMarket Movers & Accurate Buy Signal Notifications - newser.com
Minerva Neurosciences Expands Board Amid Fundraising Effort - The Globe and Mail
Minerva Neurosciences Inc Azioni (NERV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):